Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1973 1
1980 1
1982 3
1983 3
1984 4
1985 2
1986 1
1987 1
1988 4
1989 1
1990 3
1991 4
1992 7
1993 3
1994 4
1995 1
1996 2
1997 1
1998 5
1999 7
2000 2
2001 3
2002 10
2003 7
2004 8
2005 11
2006 15
2007 15
2008 20
2009 31
2010 38
2011 37
2012 41
2013 45
2014 51
2015 48
2016 39
2017 53
2018 44
2019 48
2020 75
2021 72
2022 65
2023 62
2024 62
2025 52

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

884 results

Results by year

Filters applied: . Clear all
Page 1
Human Pluripotent Stem Cell-Derived Organoids as Models of Liver Disease.
Ramli MNB, Lim YS, Koe CT, Demircioglu D, Tng W, Gonzales KAU, Tan CP, Szczerbinska I, Liang H, Soe EL, Lu Z, Ariyachet C, Yu KM, Koh SH, Yaw LP, Jumat NHB, Lim JSY, Wright G, Shabbir A, Dan YY, Ng HH, Chan YS. Ramli MNB, et al. Among authors: lim ys. Gastroenterology. 2020 Oct;159(4):1471-1486.e12. doi: 10.1053/j.gastro.2020.06.010. Epub 2020 Jun 15. Gastroenterology. 2020. PMID: 32553762 Free article.
Reply.
Choi WM, Choi J, Lim YS. Choi WM, et al. Among authors: lim ys. Clin Gastroenterol Hepatol. 2022 Feb;20(2):e342-e343. doi: 10.1016/j.cgh.2021.03.035. Epub 2021 Mar 31. Clin Gastroenterol Hepatol. 2022. PMID: 33798710 No abstract available.
Update on the treatment navigation for functional cure of chronic hepatitis B: Expert consensus 2.0.
Wu D, Kao JH, Piratvisuth T, Wang X, Kennedy PTF, Otsuka M, Ahn SH, Tanaka Y, Wang G, Yuan Z, Li W, Lim YS, Niu J, Lu F, Zhang W, Gao Z, Kaewdech A, Han M, Yan W, Ren H, Hu P, Shu S, Kwo PY, Wang FS, Yuen MF, Ning Q. Wu D, et al. Among authors: lim ys. Clin Mol Hepatol. 2025 Feb;31(Suppl):S134-S164. doi: 10.3350/cmh.2024.0780. Epub 2025 Jan 22. Clin Mol Hepatol. 2025. PMID: 39838828 Free PMC article. Review.
Reply.
Choi WM, Lim YS. Choi WM, et al. Among authors: lim ys. Clin Gastroenterol Hepatol. 2025 May;23(6):1073. doi: 10.1016/j.cgh.2024.10.039. Epub 2024 Dec 15. Clin Gastroenterol Hepatol. 2025. PMID: 39689769 No abstract available.
96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection.
Agarwal K, Brunetto M, Seto WK, Lim YS, Fung S, Marcellin P, Ahn SH, Izumi N, Chuang WL, Bae H, Sharma M, Janssen HLA, Pan CQ, Çelen MK, Furusyo N, Shalimar D, Yoon KT, Trinh H, Flaherty JF, Gaggar A, Lau AH, Cathcart AL, Lin L, Bhardwaj N, Suri V, Mani Subramanian G, Gane EJ, Buti M, Chan HLY; GS-US-320-0110; GS-US-320-0108 Investigators. Agarwal K, et al. Among authors: lim ys. J Hepatol. 2018 Apr;68(4):672-681. doi: 10.1016/j.jhep.2017.11.039. Epub 2018 Jan 17. J Hepatol. 2018. PMID: 29756595 Clinical Trial.
Evaluation of RNAi therapeutics VIR-2218 and ALN-HBV for chronic hepatitis B: Results from randomized clinical trials.
Gane E, Lim YS, Kim JB, Jadhav V, Shen L, Bakardjiev AI, Huang SA, Cathcart AL, Lempp FA, Janas MM, Cloutier DJ, Kaittanis C, Sepp-Lorenzino L, Hinkle G, Taubel J, Haslett P, Milstein S, Anglero-Rodriguez YI, Hebner CM, Pang PS, Yuen MF. Gane E, et al. Among authors: lim ys. J Hepatol. 2023 Oct;79(4):924-932. doi: 10.1016/j.jhep.2023.05.023. Epub 2023 Jun 7. J Hepatol. 2023. PMID: 37290591 Free article.
An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B.
Kim HY, Lampertico P, Nam JY, Lee HC, Kim SU, Sinn DH, Seo YS, Lee HA, Park SY, Lim YS, Jang ES, Yoon EL, Kim HS, Kim SE, Ahn SB, Shim JJ, Jeong SW, Jung YJ, Sohn JH, Cho YK, Jun DW, Dalekos GN, Idilman R, Sypsa V, Berg T, Buti M, Calleja JL, Goulis J, Manolakopoulos S, Janssen HLA, Jang MJ, Lee YB, Kim YJ, Yoon JH, Papatheodoridis GV, Lee JH. Kim HY, et al. Among authors: lim ys. J Hepatol. 2022 Feb;76(2):311-318. doi: 10.1016/j.jhep.2021.09.025. Epub 2021 Oct 2. J Hepatol. 2022. PMID: 34606915
REPLY.
Choi J, Lim YS. Choi J, et al. Among authors: lim ys. Hepatology. 2021 Jan;73(1):467. doi: 10.1002/hep.31438. Epub 2020 Dec 7. Hepatology. 2021. PMID: 32598515 No abstract available.
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study.
Yuen MF, Lim YS, Yoon KT, Lim TH, Heo J, Tangkijvanich P, Tak WY, Thanawala V, Cloutier D, Mao S, Arizpe A, Cathcart AL, Gupta SV, Hwang C, Gane E. Yuen MF, et al. Among authors: lim ys. Lancet Gastroenterol Hepatol. 2024 Dec;9(12):1121-1132. doi: 10.1016/S2468-1253(24)00237-1. Epub 2024 Oct 8. Lancet Gastroenterol Hepatol. 2024. PMID: 39389081 Clinical Trial.
884 results